Search
Fortress Biotech Inc
FBIOAdd to Watchlist
2.345USD
+0.005+0.21%
Market hours 09/24, 09:34（ET）
77.90MMarket Cap
0.61P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+0.21%
5 Days
-4.67%
1 Month
-18.29%
6 Months
-21.31%
Year to Date
-35.93%
1 Year
-35.75%
Key Figures
2.445Open
2.445High
225.00Volume
0.61P/E TTM
LossP/E Dynamic
--Dividend TTM
0.00%Turnover Ratio
2.340Prev. Close
2.330Low
527.00Turnover
LossP/E Static
0.47P/B
0.00%Div Yield TTM
48.21%ROA
4.53052wk High
0.08Volume Ratio
-55.89MNet Profit
33.22MShares
3.8490EPS TTM
1.22Beta
129.25%ROE
2.18052wk Low
4.92%Amplitude
62.00%Gross Margin
77.90MMarket Cap
-2.80Reward/Risk
4.56%Risk Rate
Fortress Biotech Inc's Score
-0.10vs previous score
Forecast8.00
Financial Health6.76
Technical3.84
Valuation Dimensions9.70
Institutional Confidence3.00
Risk Assessment3.97
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Fortress Biotech Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Fortress Biotech Inc Latest Earnings Call Transcripts
Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates
Journey Medical's Q2 2026 earnings call highlighted 23% revenue growth to $18.5 million, positive adjusted EBITDA and accelerating Emrosi prescriptions.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.08/-0.20
Revenue / Forecast
18.72M/18.30M
Fortress Biotech Inc Profile
SectorPharmaceuticals
Ticker SymbolFBIO
Number of employees101
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Rosenwald (Lindsay A) | 13.81% |
| Weiss (Michael S) | 6.85% |
| Opaleye Management Inc. | 3.28% |
| Vanguard Capital Management, LLC | 2.91% |
| Shareholder Types | Proportion |
|---|---|
| Individual Investor | 22.79% |
| Investment Advisor | 9.55% |
| Hedge Fund | 5.62% |
| Investment Advisor/Hedge Fund | 2.48% |
Related Instruments
+1.60%
+1.61%
+0.35%
+1.18%
+0.63%
+0.23%
+0.40%
-0.40%
+0.52%
+1.19%
+2.19%
+0.59%
+0.80%
+0.30%
-0.67%
+0.30%
+1.04%
+0.42%
-1.17%
+0.69%Popular Instruments
51403.400
-86.600 (-0.17%)
30243.700
-234.200 (-0.77%)
7674.500
-32.500 (-0.42%)
14267.000
-155.000 (-1.07%)
65623.000
-506.000 (-0.77%)
6295.400
+5.400 (+0.09%)
93.833
+1.343 (+1.45%)
336.470
-0.550 (-0.16%)
221.710
-3.800 (-1.69%)
4272.470
-13.770 (-0.32%)
FAQs
What is the current price of Fortress Biotech Inc (FBIO)?
The current price of Fortress Biotech Inc (FBIO) is 2.34.
What is the symbol of Fortress Biotech Inc?
The ticker symbol of Fortress Biotech Inc is FBIO.
What is the 52-week high of Fortress Biotech Inc?
The 52-week high of Fortress Biotech Inc is 4.53.
What is the 52-week low of Fortress Biotech Inc?
The 52-week low of Fortress Biotech Inc is 2.18.
What is the market capitalization of Fortress Biotech Inc?
The market capitalization of Fortress Biotech Inc is 77.73M.
Is Fortress Biotech Inc (FBIO) currently rated as Buy, Hold, or Sell?
According to analysts, Fortress Biotech Inc (FBIO) has an overall rating of Buy, with a price target of 5.00.
What is the Earnings Per Share (EPS TTM) of Fortress Biotech Inc (FBIO)?
The Earnings Per Share (EPS TTM) of Fortress Biotech Inc (FBIO) is 3.85.